Over the past 12‑18 months the Palm and Fingers Orthosis Devices market has accelerated through a mix of strategic alliances, tech roll‑outs, and regulatory shifts that reshape adoption pathways. In early 2024, OrthoFlex partnered with Siemens Healthineers to embed AI‑driven motion analytics into its custom‑fit splints, a move that shortened clinician setup time by 30 %. The same year, MediGrip completed its acquisition of HandTech Ltd., expanding its portfolio into 3‑D printed polymer orthoses and unlocking new reimbursement codes in the EU. A notable product launch came from TheraWear, whose sensor‑integrated wrist‑finger brace received FDA 510(k) clearance, enabling real‑time strain monitoring for post‑surgical patients. Meanwhile, the FDA’s updated guidance on additive‑manufactured medical devices, released in Q3 2023, has prompted manufacturers to adopt tighter validation protocols. Consumer demand is shifting toward at‑home rehabilitation solutions, driving a 22 % YoY rise in tele‑therapy‑compatible orthoses. Finally, FlexiHand secured a $45 million Series C round to scale its cloud‑based fitting platform across North America and Asia, positioning it for rapid market penetration, reflecting broader Palm and Fingers Orthosis Devices industry trends.
